KPTI icon

Karyopharm Therapeutics

78 hedge funds and large institutions have $704M invested in Karyopharm Therapeutics in 2014 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 30 increasing their positions, 18 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
78
Holders Change
+18
Holders Change %
+30%
% of All Funds
2.24%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
29
Increased
30
Reduced
18
Closed
10
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
GSC
76
Ground Swell Capital
South Carolina
$6K +$6K +9 New
Citigroup
77
Citigroup
New York
$5K -$2.86K -4 -36%
BNP Paribas Financial Markets
78
BNP Paribas Financial Markets
France
$1.58K
Principal Financial Group
79
Principal Financial Group
Iowa
-$1.98M -4,267 Closed
EI
80
EAM Investors
California
-$1.97M -4,253 Closed
UBS AM
81
UBS AM
Illinois
-$1.44M -3,107 Closed
RFC
82
Russell Frank Company
Washington
-$1.05M -2,746 Closed
Ameriprise
83
Ameriprise
Minnesota
-$845K -1,825 Closed
FM
84
Forward Management
California
-$396K -1,439 Closed
ARTA
85
A.R.T. Advisors
New York
-$471K -1,018 Closed
AI
86
Analytic Investors
California
-$273K -589 Closed
BJ
87
BlackRock Japan
Japan
-$61K -131 Closed
TRCT
88
Tower Research Capital (TRC)
New York
-$4K -9 Closed